Indigenous Tourism: Experience the Vast Tapestry of Native Culture

The term ‘Indigenous’ comes from the Latin term ‘indigenus’ which literally means ‘sprung from the land’. The word has different terms from one country or one culture to another, but it primarily refers to the original inhabitants of the region. This is usually for the natives who lived in countries which were eventually colonised by European settler populations. Some examples include the First Nation, Metis and Inuk of Canada, Aborigines of Australia, and American Indians or Native Americans in the U.S. Indigenous tourism is defined as a form of tourism where indigenous people are involved either through direct control, or their culture is the main attraction.

A tourist visiting an indigenous attraction may witness cultural tourism by looking at a fish wheel and understanding the modern day importance of salmon to the natives for example. Some examples of indigenous tourism are restaurants serving indigenous food, hotels, wineries, resorts or gambling casinos owned by the indigenous people, museums or interpretative centres and eco-tourism activities like whale watching, dog sledging trips, trail riding, and fishing and hunting expeditions. Indigenous tourism is currently one of the fastest growing subsets of the industry and can provide economic opportunities and employment to the locals who may have been historically wronged by settler communities.

Request For Report Sample: http://www.futuremarketinsights.com/reports/sample/rep-gb-3009

Indigenous Tourism: Drivers

A desire for greater cultural understanding is one of the biggest drivers of indigenous tourism. The relations between white settler European populations and the natives of North America and Australia were never very harmonious from the 16th century all the way up to the 20th century. In the 21st century, there is a noted increase in the number of individuals wanting to understand the customs, traditions, and way of life of the indigenous people to foster communal harmony and improve inter-community bonding. The second driver could be government encouragement. Indigenous tourism is both a revenue generator and employment opportunity for the native people who have faced severe hardships like disease, poverty, illiteracy and neglect through the centuries. As per information from the University of British Columbia, indigenous tourism generates $750 million of revenue on an annual basis in Canada alone. Thus, there is strong government support for promoting and developing indigenous tourism.

Indigenous Tourism: Restraints

There are some challenges faced by the indigenous tourism sector today. A major one is inadequate government funding. While governments of countries like the U.S, Canada, Australia and New Zealand have recognised the importance of their indigenous people and have pledged to support them, it is not enough at the present time. The second issue may be that of marketing these tours. Potential tourists may be scattered in different locations around the world, and speak several different languages. They might also have psychological barriers and be worried about the safety of these excursions. The Internet and word of mouth have gone a long way in eliminating most of these concerns. The third challenge is preserving the indigenous communities’ way of life. There is a risk that heavy commercialization and exploitation may make these communities assimilate into mainstream society, which may make them lose their customs and traditional way of life. The government might even impose strict quotas on the number of tours allowed, restraining the unencumbered growth of the indigenous tourism segment.

Request For TOC: http://www.futuremarketinsights.com/toc/rep-gb-3009

Indigenous Tourism: Key Regions

The main regions for indigenous tourism are Australia, Canada, New Zealand, and the U.S. Some tours include mud crabbing, whale watching, kayaking, fishing, hunting, sledding, and 4WD tours.

Indigenous Tourism: Players

Some companies offering indigenous tourism packages in various countries include indigenous tours WA, indigenous tours & charters, Aboriginal Australia Tours, Broome visitor centre, Lomdadina indigenous tours, and Indigenous Walks.

This comprehensive report equips readers with lucid information and analysis on the sector. Future Market Insights’ experienced travel and tourism analysts bring to you accurate and unbiased information to help you make crucial decisions with confidence.

Browse Full Report: http://www.futuremarketinsights.com/reports/indigenous-tourism-sector-overview

The report offers a 360° view – bringing to the fore key drivers, restraints, opportunities, and challenges prevailing in the sector. To offer readers actionable insights, detailed information on historical trends, current scenario, and future projections is provided in the report.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

Title:
Membrane Chemical Market Expected to Account for US$ 5,572.8 Mn by 2020
Radiopharmaceuticals Market Will hit at a CAGR of 5.9% by 2016 to 2026
Radiopharmaceuticals Market expected to grow at a CAGR of 5.9% during 2016 to 2026
Radiopharmaceuticals Market to Grow at a CAGR of 5.9% through 2026
Renewable Methanol Market by Primary Source: Biomass, Municipal Waste, Industrial Waste and Others
Hypercalcemia Treatment Market by End-use Application: Formaldehyde, MTBE, Gasoline, Dimethyl Ether and Solvents
Radiopharmaceuticals Market Poised to Rake US$ 8,500 million by 2026
Valuation of Radiopharmaceuticals Market to reach US$ 8,500 million by 2026
Radiopharmaceuticals Market Revenue is expected to US$ 8,500 million by 2026
Summary:
Future Market Insights has announced the addition of the “Radiopharmaceuticals Market: Global Industry Analysis and Opportunity Assessment, 2016–2026" report to their offering.
Radiopharmaceuticals Market, Radiopharmaceuticals, Radiopharmaceuticals Market sales, Radiopharmaceuticals Market size, Radiopharmaceuticals Market Forecast, U.K Radiopharmaceuticals Market, U.S Radiopharmaceuticals Market, India Radiopharmaceuticals Market.

North America is anticipated to be the most attractive regional market in the global radiopharmaceuticals market
North America accounted for more than 40% market share in the global radiopharmaceuticals market in 2016 and is expected to witness an increase of more than 100 BPS in its market share over the forecast period. In terms of Y-o-Y growth, North America dominated the global radiopharmaceuticals market and was valued at more than US$ 2,000 Mn in 2015. The market is expected to expand at 6.2% CAGR over the projected period to reach more than US$ 4,000 Mn by the end of 2026. The North America radiopharmaceuticals market is estimated to represent absolute $ opportunity of more than US$ 100 Mn in 2017 over 2016. The growth is stagnant and slow due to major reactors having been shut down in Canada and new reactors installed in place of old ones for better production of radioisotope. North America is expected to be the most lucrative market in the global radiopharmaceuticals market, recording an attractiveness index of 3.6.
Significant growth in the number of cancer and cardiovascular diseases patients in North America is expected to boost the global radiopharmaceuticals market
Widespread availability of SPECT and PET scanning machines will result in a growing number of radio diagnostic and radio therapeutics events in North America. For instance, the number of PET scanning machines installed per head of population in North America are more compared to that installed in Europe, thus leading to increased usage of radiotracers in the region. This growth in North America is expected to continue along with continuous technological improvements in PET scanning devices. The high level of awareness and accessibility to these machines is expected to account for high revenue generation in North America. This factor is boosting the overall growth of the global radiopharmaceuticals market. The other factor impacting the global radiopharmaceuticals market is the rising prevalence of cancer in North America. This has significantly increased the number of nuclear medicine procedures performed in the region and this is the precise reason that the market for radiopharmaceuticals is steadily growing in North America. There has been a rising number of cardiovascular diseases among the people in North America due to aging population, unhealthy food habits and rising obesity. The increasing number of cardiovascular patients is expected to boost the sales of radiopharmaceuticals, which would eventually create growth in the global radiopharmaceuticals market.
Request For Report Sample: http://www.futuremarketinsights.com/reports/sample/rep-gb-1992
Gallium-68 and Lutetium 177 sub-segments of the radioisotope segment are likely to dominate the North America radiopharmaceuticals market
Gallium-68 and Lutetium 177 are dominant sub-segments of the radioisotope segment in North America. Gallium-68 has gained immense popularity since the last one year in the field of nuclear medicine, especially in the diagnosis and evaluation of prostate cancer. This is in heavy reliance with incorporation of several technological leaps and entry of new radiotracer- 68Ga-PSMA-11, developed by the University of Heidelberg. Additionally, marketing authorisation of the first 68Ge/68Ga generator, manufactured by the German company Eckert & Ziegler, has also positively impacted the penetration of 68Ga-PSMA-11 tracer in the treatment of prostate cancer in North America. Despite a shorter half-life, Gallium-68 has an ideal profile as a PET imaging agent. Several manufacturers in North America are focussing on introducing cold kits for the 68Ga-labeling of tracers (ANMI, Belgium), thus opening the gateways for 68Ga in PET scanning. Iodine-131, a therapeutic radiotracer continues to be the ideal tracer for the treatment of not only thyroid cancer but also other therapeutic indications. However it is being slowly replaced by Lutetium-177 (Lu-177) in North America. Lu-177, low-energy β-particle emitter is identified to be one of the emerging radiotracers for the treatment of metastatic castrate-resistant prostate cancer (mCRPC) and neuroendocrine tumors.
Send An Enquiry: http://www.futuremarketinsights.com/askus/rep-gb-1992

Market share of companies operating in the global radiopharmaceuticals market
The global radiopharmaceuticals market is highly consolidated with a few companies that offer advanced technology systems and nuclear medicines for treating diseases. However, the global market is dominated by top five players accounting for over 89% share. Siemens Healthineers accounted for the largest share of around 41.2% of the global market in 2015. The company dominated the market owing to its diversified product portfolio, extensive geographical presence, and acquisition strategies. GE Healthcare accounted for the second largest share of around 30.1% and Mallinckrodt plc. accounted for the third largest share of around 9% in the global radiopharmaceuticals market.
Browse Full Report Radiopharmaceuticals Market Segmentation by Radioisotope – Technetium-99, Fluorine-18, Iodine-131, Leutetium-177, Yttrium-90, Gallium-68, Gallium-67, Rubidium-82, Iodine-123, Iodine-125, Indium-111; By Source – Cyclotrons, Nuclear Reactors; By Application – Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, Nephrology; By End User – Hospitals, Diagnostic Imaging Centres, Ambulatory Surgical Centres, Cancer Research Institutes: http://www.futuremarketinsights.com/reports/radiopharmaceuticals-market
ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.
CONTACT:
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.